Fake medicines, stolen organs and a new deal between the WHO and Interpol
What happened
On 16 October 2026, the World Health Organization (WHO) and Interpol signed a cooperation agreement. The two organisations announced it in a joint news release datelined Geneva and Lyon, the cities where their head offices sit. The agreement sets up a framework for the two bodies to work together. The idea is simple: Interpol knows how to police crime across borders, and the WHO knows how to protect public health. The agreement puts those two kinds of knowledge in the same room. The news release lists five areas where they will cooperate. The first is unusual and serious situations that need both a health response and a security response at the same time. The release gives examples: the suspected misuse of chemical or radioactive materials, and unusual biological events, whether these happen naturally, by accident, or on purpose. The second is big international events and mass gatherings. The two bodies will help countries prepare for health threats around them. The third is the trafficking of people for organ removal, and the illegal trade in human organs, tissues and cells. The fourth is the illegal making and selling of goods that affect people's health. The release names falsified medical products, counterfeit protective equipment, unsafe or wrongly labelled food and drink, and illegally produced alcohol. The fifth is support for countries putting the WHO Framework Convention on Tobacco Control into practice. That is the international treaty on tobacco. Valdecy Urquiza, Interpol's Secretary General, said: "Crime and health are increasingly interconnected." He added that the agreement "strengthens our ability to work with the World Health Organization to protect communities." Dr Tedros Adhanom Ghebreyesus, the WHO's Director-General, said: "Health security is global security." He said the collaboration helps "protect people from threats that undermine both health systems and public trust.
Why this matters
At first glance this looks like paperwork between two large organisations. It is worth a second look, because of what is on the list. Falsified medicines are the item most likely to touch an ordinary household. A falsified medicine is one that is deliberately made to look like the real thing but is not. It might contain the wrong amount of the active ingredient, a different drug altogether, or nothing useful at all. That is not a distant problem. In the UK, the medicines regulator has been seizing fake weight-loss injection pens. Only the day before this agreement was signed, the Medicines and Healthcare products Regulatory Agency announced a seizure of counterfeit pens worth around £2 million, working with West Midlands Police. The pattern is the same one the WHO and Interpol are describing: a medicine in high demand, a supply chain under pressure, and criminals filling the gap. The second reason this matters is less obvious. Fake medicines damage trust. If you cannot be sure that the box in your hand is genuine, you start to doubt all medicine, including the genuine kind. Dr Tedros pointed at exactly this when he talked about threats that undermine "public trust". Losing trust in medicine is its own kind of harm, separate from the harm the fake product does. The third reason is the organ trafficking item. This is rare, and most people will never come near it. But it is a crime that sits exactly on the line between policing and healthcare, and neither side can deal with it alone. Police need medical expertise to understand what they are looking at. Health systems need police powers to stop it.
What the evidence actually says
It is worth being careful here, because an agreement is not a result. What has been announced is a framework for working together. The news release describes how the two organisations will cooperate. It does not announce arrests, seizures, new laws, or new money. It does not set targets or deadlines. No figures were published about how big any of these problems are. So the honest summary is this: two organisations with different powers have agreed a formal way to share information and coordinate. Whether that makes a measurable difference will depend on what happens next, in individual countries, over years. It is also worth saying what the agreement does not change for you. The rules on who can sell you medicine in the UK have not changed. The medicines on your repeat prescription have not changed. Nothing in this announcement means a medicine you already take is suspect. What has changed is the amount of international coordination behind the scenes. That is genuinely useful, and it is also slow and invisible. Both things are true.
Qurexa perspective
This is one of the few news stories where a pharmacy delivery service has something concrete to say, so we will say it plainly. The whole point of a regulated supply chain is that you never have to judge a medicine by looking at it. Genuine medicines reach UK patients through a chain of licensed wholesalers and registered pharmacies. Every step is recorded. If something goes wrong with a batch, it can be traced and recalled. That chain is the thing criminals have to get around. They do it by going directly to the public, usually online, usually at a price that looks too good, and usually for a medicine that is hard to get hold of. At Qurexa, prescriptions are dispensed by a registered pharmacy and delivered to the patient's door. The reason that matters in the context of this story is not the delivery. It is that the medicine never leaves the regulated chain. There is no point at which you are buying from someone you cannot check. We would rather say that than pretend this story is mainly about us. It is not. It is about international crime, and the two bodies best placed to tackle it agreeing to work together.
Practical advice
Here are the steps that actually protect you. Use a registered pharmacy. In Great Britain, you can check whether a pharmacy is registered on the General Pharmaceutical Council register. In Northern Ireland, it is the Pharmaceutical Society of Northern Ireland. A legitimate online pharmacy will say who it is regulated by and give a registration number. Be very careful with prescription-only medicines sold without a prescription. If a website will sell you a weight-loss injection, an antibiotic or a strong painkiller with no questions asked, that is the warning sign. A genuine service asks questions because it has to. Treat social media sellers and messaging-app sellers as unsafe. This is where most of the fake weight-loss pens have been turning up. Look at the price. A large discount on a medicine that is in short supply is not a bargain. It is the most common sign of a fake. Check the packaging if you can, but do not rely on it. Good counterfeits look good. Packaging is a weak test, which is why the supply chain matters more. If you think you have been sold a fake medicine in the UK, report it to the MHRA through its Yellow Card scheme. If you have taken it and feel unwell, contact your GP, your pharmacist, or NHS 111. If you are seriously unwell, call 999. And if you are not sure about a medicine you already have at home, ask a pharmacist. It is free, it takes a few minutes, and it is exactly the kind of question they are there for.
What to know
The WHO and Interpol signed a cooperation agreement on 16 October 2026. It covers five areas: joint health and security emergencies, mass gatherings, organ trafficking, illegally made goods that harm health including falsified medicines, and support for the global tobacco treaty. It is a framework, not a result. No arrests, targets, figures or funding were announced with it. The part most likely to affect ordinary people is falsified medicines, and the practical protection has not changed: get medicines through a registered pharmacy, be suspicious of prescription-only drugs sold without a prescription, and treat a surprising discount as a warning rather than a win. Nothing in this announcement casts doubt on medicines you already get on prescription. Sources: World Health Organization and Interpol, "INTERPOL and WHO sign agreement to strengthen global health and security protection", 16 October 2026, https://www.who.int/news/item/16-10-2026-interpol-and-who-sign-agreement-to-strengthen-global-health-and-security-protection ; Interpol, "INTERPOL and WHO sign agreement to strengthen global health and security protection", 16 October 2026, https://www.interpol.int/en/News-and-Events/News/2026/INTERPOL-and-WHO-sign-agreement-to-strengthen-global-health-and-security-protection ; GOV.UK (Medicines and Healthcare products Regulatory Agency), "Counterfeit weight loss pens worth £2 million seized by MHRA and West Midlands Police", 15 October 2026, https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional. If you are worried about a medicine you have been supplied, speak to a pharmacist before you stop or change anything.
Related articles
44% of over-75s are active, against 64% of 55 to 74s: the government replies
On 22 October 2026 the government published its formal reply to a report by the House of Commons Health and Social Care Committee. The committee's report is ca…
£9.4 million to move mental health workers into children's social care teams
On 23 October 2026 the government announced a new mental health pilot for children and young people who are supported by children's social care. The pilot is c…
One tablet a day: the UK has licensed a new psoriasis treatment
On 23 October 2026 the Medicines and Healthcare products Regulatory Agency (MHRA) licensed a new medicine for plaque psoriasis. The medicine is called icotroki…